Kelmar
Patricia
Kelmar
Senior Director, Health Care Campaigns, U.S. PIRG Education Fund
Kelmar
Patricia
When patients feel the pain of high drug prices, the Patent Office should take notice
How to fight medical debt on your credit report – Consumer Protection Week 2024
Consumer Protection Week 2024: Advice for everyone trying to navigate today’s complex marketplaces
PIRG offers expert tips on protecting your privacy, avoiding scams, identifying reliable cell phones and more
Major step forward to help people struggling with impact of medical debt
Consumer Financial Protection Bureau Director Chopra announced proposals to protect people struggling with medical debt.
Release: New Guide Helps People Avoid, Dispute Unnecessary Medical Bills
Resource directs patients through complexities of medical billing, empowers them to assert rights
SCOTUS action will limit generic drug competition
U.S. Supreme Court on Monday declined to review a federal circuit court decision that imperils a critical method that many generic drug makers use to win approval. The court denied a petition of certiorari in Teva Pharmaceuticals USA, Inc. V GlaxoSmithKline LLC, Et. Al., allowing the divided lower court's decision to stand. This action can have dramatically limit competition from lower-priced generic and biosimilar medicines.
NEW REPORT: Rx patent abuse tactics block generic drugs
New report explains how drug companies manipulate patents to prevent competition
Interview opportunity: New CMS guidance for arbitrators of out-of-network surprise billing payment disputes
Expert on ‘No Surprises Act’ available to explain potential negative impact on patients, consumers